TY - JOUR
T1 - Molecular epidemiology of ESBL-producing E. Coli and K. pneumoniae
T2 - Establishing virulence clusters
AU - Surgers, Laure
AU - Boersma, Peter
AU - Girard, Pierre Marie
AU - Homor, Audrey
AU - Geneste, Delphine
AU - Arlet, Guillaume
AU - Decré, Dominique
AU - Boyd, Anders
N1 - Funding Information: LS received a grant from the “Fondation pour la Recherche Médicale” (DEA20140630021). AB received post-doctoral funding from SIDACTION. PB received a Martinson-Luep-ker Student Travel Award from the University of Minnesota for the work presented in this manuscript. The authors report no other conflicts of interest in this work. Publisher Copyright: © 2019 Surgers et al.
PY - 2019
Y1 - 2019
N2 - Objective: To genetically characterize clusters of virulence factors (VFs) among extended spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae and assess whether these clusters are associated with genetic determinants or clinical outcomes. Methods: One hundred forty-eight E. coli and 82 K. pneumoniae clinical isolates were obtained from 213 patients in Paris, France. Isolates underwent ESBL characterization, MultiLocus Sequence Typing (MLST) typing and phylogenetic group identification. Detection of ten E. coli and seven K. pneumoniae VF-encoding genes were assessed, from which a k-medians partition algorithm with Jaccard similarity measure was used to construct clusters. Results: CTX-M was the predominant ESBL and susceptibility to trimethoprim–sulfamethoxa-zole (32%), ciprofloxacin (22%) and aminoglycosides (32%) was low. In E. coli, there were five identified clusters, with significantly different distributions of ESBL-sequence type (P<0.001), ST131 (P<0.001) and phylogenetic group (P=0.001) between clusters. “Siderophore exclusive”, “siderophore exclusive with iroN ” and “adhesin sfa/papGIII-rich” clusters had higher 12-month mortality rates compared to others (49% vs 22%, respectively, P=0.02). In K. pneumoniae, three different clusters, with significantly different distributions of aminoglycoside-sensitivity (P<0.004), MLST-type (P<0.001) and relaxase plasmids (P=0.001) were described. Conclusion: Distinct clusters of E. coli and K. pneumoniae VFs are observed within ESBL-producing isolates and are strongly associated with several genetic determinants. Their association with overall morbidity and mortality requires further evidence.
AB - Objective: To genetically characterize clusters of virulence factors (VFs) among extended spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae and assess whether these clusters are associated with genetic determinants or clinical outcomes. Methods: One hundred forty-eight E. coli and 82 K. pneumoniae clinical isolates were obtained from 213 patients in Paris, France. Isolates underwent ESBL characterization, MultiLocus Sequence Typing (MLST) typing and phylogenetic group identification. Detection of ten E. coli and seven K. pneumoniae VF-encoding genes were assessed, from which a k-medians partition algorithm with Jaccard similarity measure was used to construct clusters. Results: CTX-M was the predominant ESBL and susceptibility to trimethoprim–sulfamethoxa-zole (32%), ciprofloxacin (22%) and aminoglycosides (32%) was low. In E. coli, there were five identified clusters, with significantly different distributions of ESBL-sequence type (P<0.001), ST131 (P<0.001) and phylogenetic group (P=0.001) between clusters. “Siderophore exclusive”, “siderophore exclusive with iroN ” and “adhesin sfa/papGIII-rich” clusters had higher 12-month mortality rates compared to others (49% vs 22%, respectively, P=0.02). In K. pneumoniae, three different clusters, with significantly different distributions of aminoglycoside-sensitivity (P<0.004), MLST-type (P<0.001) and relaxase plasmids (P=0.001) were described. Conclusion: Distinct clusters of E. coli and K. pneumoniae VFs are observed within ESBL-producing isolates and are strongly associated with several genetic determinants. Their association with overall morbidity and mortality requires further evidence.
KW - E. Coli
KW - ESBL
KW - K. Pneumoniae
KW - Mortality
KW - Virulence
UR - http://www.scopus.com/inward/record.url?scp=85059448987&partnerID=8YFLogxK
U2 - https://doi.org/10.2147/IDR.S179134
DO - https://doi.org/10.2147/IDR.S179134
M3 - Article
SN - 1178-6973
VL - 12
SP - 119
EP - 127
JO - Infection and Drug Resistance
JF - Infection and Drug Resistance
ER -